Immunology of Human Papillomaviruses

  • Margaret A. Stanley

Table of contents

  1. Front Matter
    Pages i-xi
  2. HPV Gene Expression

    1. Ilona Lewensohn-Fuchs, Eva Munck-Wikland, Zsofia Berke, Gorm Pallesen, Annika Linde, Klas G. Wiman et al.
      Pages 15-20
    2. Louise J. Clark, Kenneth MacKenzie, E. Kenneth Parkinson
      Pages 21-24
    3. Thomas Iftner, Stephan Böhm, Martin Oft, Sharon P. Wilczynski, Herbert Pfister
      Pages 25-31
    4. V. Bouvard, A. Storey, D. Pim, E. Baraggino, U. Wisenfeld, L. Banks
      Pages 33-38
    5. Klaus F Czerwenka, Yongxian Lu, Friedrich Heuss, Mahmood Manavi, Josef W Hosmann, Darco Jelencic et al.
      Pages 39-43
    6. Eileen Epsaro, Jarrett Burton, Sheila Mathieson, Joseph Merola, Jeffrey A. Sands
      Pages 45-49
    7. Ingeborg Zehbe, Eva Rylander, Jan Sällström, Erik Wilander
      Pages 55-58
    8. Martine Chabaud, Nubia Munoz, Marie Claude Cottu, Pierre Coursaget, Philippe Anthonioz, Nicolas Day et al.
      Pages 59-62
    9. Olaf Arndt, Josef Brock, Ingrid Bauer, Günter Kundt
      Pages 63-69
    10. Farzin Pakarian, Jeremy Kaye, John Cason, Barbara Kell, Richard Jewers, Kankipati S. Raju et al.
      Pages 71-74
  3. Humoral Responses to HPV

    1. V. Vonka, E. Hamsiková, J. Novák, V. Hofmannová, N. Munoz, S. de Sanjosé et al.
      Pages 85-90
    2. Anna Di Lonardo, M. Saveria Campo, M. Luisa Marcante
      Pages 103-107
    3. Pierre Le Cann, Didier Leboulleux, Catherine Bernard, Cecile Calvet, Marie Christine Legrand, Gerard Lesage et al.
      Pages 109-111

About this book


This volume represents a series of papers presented at the Second International Workshop on HPV Immunology held at the University of Cambridge July 5-7 1993. This Workshop and its predecessor held in Amsterdam in May 1992 were two of the major activities of the European Concerted Action "Immunology of Human Papillomavirus and Vaccine Development". The Concerted Action (CA) was supported by grants from the Commission of the European Communities (EC), the French Association for Cancer Research (ARC) and the European Association for Medical Research (EAMR). Twenty­ two laboratories throughout Europe and Scandinavia were members of the CA, the objectives of which were to develop collaborations, implement scientific exchanges and co-operate in a collective effort to develop vaccination strategies for HPV. HPV's are ubiquitous pathogens and evidence which has been accumulated over the past decade leaves little doubt that infection with certain HPV types (the so called "oncogenic HPV's" 16, 18 and their relatives) is the major risk factor in the development of cancer of the uterine cervix in women. Since an infectious agent, a virus, is implicated as the main aetiologic factor in this disease, the possibility is raised that if one could prevent HPV infection or treat established infections this would be an effective anti-cancer strategy against what is the commonest cancer in women worldwide.


Antigen antigen presentation cancer cell development evolution gene expression growth histocompatibility immunology infection infections skin vaccine virus

Editors and affiliations

  • Margaret A. Stanley
    • 1
  1. 1.Department of PathologyUniversity of CambridgeCambridgeUK

Bibliographic information

  • DOI
  • Copyright Information Plenum Press, New York 1994
  • Publisher Name Springer, Boston, MA
  • eBook Packages Springer Book Archive
  • Print ISBN 978-1-4613-6041-4
  • Online ISBN 978-1-4615-2449-6
  • About this book